http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2007138266-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-46
filingDate 2006-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2009-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2007138266-A
titleOfInvention COMBINATION OF STEROID SULFATASE INHIBITOR AND ASCOMYCIN
abstract 1. Ascomycin in combination with a steroid sulfatase inhibitor. ! 2. The combination of a steroid sulfatase inhibitor and ascomycin for use as a pharmaceutical. ! 3. The use of a combination of a steroid sulfatase inhibitor and ascomycin for the manufacture of a medicament for the treatment of inflammatory disorders. ! 4. A method of treating inflammatory disorders, which consists in the fact that a therapeutically effective amount of a combination of a steroid sulfatase inhibitor and ascomycin is administered to a subject in need of such treatment. ! 5. A pharmaceutical composition comprising a mixture of at least one pharmaceutically acceptable excipient, a pharmaceutically effective amount of at least one steroid sulfatase inhibitor in combination with at least one ascomycin. ! 6. The combination, use, method or pharmaceutical composition according to any one of the preceding paragraphs, in which ascomycin means a compound of the formula! 7. The combination, use, method or pharmaceutical composition according to any one of the preceding paragraphs, in which the steroid sulfatase inhibitor means a compound of the formula
priorityDate 2005-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9549174
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24800
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08842
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP50427
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20905
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426068155
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID509206
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426146200
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282071

Total number of triples: 30.